Clement Ma - Concepedia

Author

Clement Ma

Harvard University ORCID

Also Known As

Adam Locke, C Ma, C-H Ma, C. Ma, Chongran Ma, Clement Ma, G. Cerchiaro, Lind, Lars, M A Clement, Ma, Clement

261

Publications

6.8K

Citations

H-Index

159

Concepts

All Affiliations

Harvard University University of Toronto Boston Children's Hospital Dana-Farber Cancer Institute Princess Margaret Cancer Centre

About

Clement Ma is an author at Harvard University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	151
2	Business	2	2	246
3	Education	2	2	246
4	Management	2	2	246
5	Engineering	1	1	23

Clement Ma

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
The genetic architecture of type 2 diabetes Christian Fuchsberger, Jason Flannick, Tanya M. Teslovich, Nature Genetic DeterminantGeneticsDiabetesGenetic EpidemiologyType 2	2016	1.1K
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans Robert A. Scott, Laura J. Scott, Reedik Mägi, Diabetes	2017	796
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci Kyle J. Gaulton, Teresa Ferreira, Yeji Lee, Nature Genetics Genome-wide Association StudyGenetic DeterminantGenotype-phenotype AssociationGenetic Fine MappingGenetics	2015	420
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients Nicole G. Chau, Clement Ma, Kristina Danga, JNCI Cancer Spectrum	2019	210
Comparison of Health-Related Quality of Life 5 Years After SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial Juanita Crook, Alfonso Gómez‐Iturriaga, Kris Wallace, Journal of Clinical Oncology	2010	188
Recommended Joint and Meta‐Analysis Strategies for Case‐Control Association Testing of Single Low‐Count Variants Clement Ma, Tom Blackwell, Michael Boehnke, Genetic Epidemiology	2013	163
Interconversion of three measures of performance status: An empirical analysis Clement Ma, Shazeen Bandukwala, Debika Burman, European Journal of Cancer Total Quality ManagementPerformance ManagementProductivityPerformance StudiesHuman Performance Measuring	2010	156
Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation Katja G. Weinacht, Louis‐Marie Charbonnier, Fayhan Alroqi, Journal of Allergy and Clinical Immunology Signal TransductionAutoimmune DiseaseAllergyAutoantibody ProductionImmune Cell Development	2017	156
Radiation therapy in the management of the primary penile tumor: an update Juanita Crook, Clement Ma, L. Grimard World Journal of Urology Adaptive RadiotherapyPrimary Penile TumorSurgical OncologyRadiation MedicineUrology	2008	128
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials Paul Wheatley‐Price, Fiona Blackhall, Siow Ming Lee, Annals of Oncology Non-small-cell Lung CancerCancer ScreeningMedicineRandomized TrialsGynecology	2010	119

Page 1